Timothy Alexander

Housing Supply Hits Six-Year High as Buyers Gain Leverage U.S. housing inventory climbed to its highest level since 2020 in August as new listings accelerated while sales remained weak, giving buyers more […]

Empowered Funds to Liquidate Two Emerging-Market ETFs NEWTOWN SQUARE, PA — Empowered Funds LLC will liquidate two Sophus Capital emerging-market exchange-traded funds on or about Sept. 28, ending trading a […]

Universal Health Realty Sets 75-Cent Quarterly Dividend KING OF PRUSSIA, PA — Universal Health Realty Income Trust (NYSE: UHT) will pay a quarterly dividend of 75 cents per share on Sept. 30, returning c […]

Harbor Compliance Targets Expansion After Majority Investment LANCASTER, PA — Harbor Compliance is expanding its regulatory data, software and managed-services business following a majority investment from B […]

Factor4 Extends Gift Card Tools to MyPOS Connect Retailers BROOMALL, PA — Factor4 is integrating its gift card and loyalty technology with Tri-City Retail Systems’ MyPOS Connect platform, extending physical a […]

eMoney Draws 1,300 Advisors to Virtual Planning Summit RADNOR, PA — eMoney Advisor expects more than 1,300 financial professionals to attend its three-day virtual Summit beginning Oct. 19, using the event t […]

Ascensus Names Edward Greene HR Chief as Company Grows DRESHER, PA — Ascensus named Edward Greene chief human resources officer effective Sept. 14, placing the former Iron Mountain HR executive in charge o […]

Chester County Home Prices Defy National Housing Slowdown WEST CHESTER, PA — Chester County home prices continued to rise in August even as the national housing market weakened, with constrained local i […]

AMREP Profit Sinks as Land, Home Sales Weaken HAVERTOWN, PA — AMREP Corporation’s (NYSE: AXR) first-quarter profit fell 94% as land and home sales contracted sharply, while the New Mexico real est […]

HOPE Adds Robotic TMS System Ahead of SPARC Trial WILMINGTON, DE — NRx Pharmaceuticals Inc. said its HOPE Therapeutics subsidiary will become the first interventional psychiatry network to deploy Z […]

West Chester Moves to Repeal $1.2 Million Stormwater Fee WEST CHESTER, PA — West Chester Borough Council will consider repealing its Stream Protection Fee Ordinance on Wednesday, formally dismantling a s […]

FCC Clears WHYY Acquisition of WPSU Broadcast Licenses PHILADELPHIA, PA — The Federal Communications Commission approved the transfer of WPSU’s broadcast licenses from Penn State University to WHYY, c […]

Vishay Raises Surge Protection Capacity With New TVS Line MALVERN, PA — Vishay Intertechnology Inc. (NYSE: VSH) introduced a series of transient voltage suppressors that increases peak pulse current while r […]

Coventry Pushes Life Settlements as Policies Lose Value FORT WASHINGTON, PA — Coventry is urging life insurance policyowners and financial advisers to assess whether existing policies can be sold rather t […]

ETC Sells Polish Unit, Keeps 10-Year Supply Agreement SOUTHAMPTON, PA — Environmental Tectonics Corp. (OTCID: ETCC) sold its wholly owned Polish subsidiary, ETC-PZL Aerospace Industries sp. z o.o., as t […]

Instinct Science Launches AI Clinical Assistant for Vets PHILADELPHIA, PA — Instinct Science is preparing to expand access to Attending, an AI clinical assistant for veterinarians that draws from p […]

Verrica Data Show YCANTH Response Across Disease Duration WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) will present new Phase 3 analyses showing its FDA-approved YCANTH treatment produced h […]

ZeroEyes Expands Gun Detection Across Muscogee Properties PHILADELPHIA, PA — ZeroEyes expanded its AI-based gun detection software to two newly developed Muscogee Nation Gaming Enterprises properties as the O […]

ISYMI: Medicus Picks 200-Mcg SkinJect Dose for Gorlin Program PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) selected the 200-mcg dose of its SkinJect patch for further development after completing a P […]

Prelude Wins FDA Clearance to Move Breast Cancer Drug to Trial WILMINGTON, DE — Prelude Therapeutics Inc. (Nasdaq: PRLD) received U.S. Food and Drug Administration clearance to begin a Phase 1 trial of PRT13722, m […]